Evidence map›Paper›PMID 37598228›Full record

SynthesisTranslational psychiatry2023

Brain-cognition relationships in late-life depression: a systematic review of structural magnetic resonance imaging studies.

Tulip Marawi, Nicholas J Ainsworth, Peter Zhukovsky, Neda Rashidi-Ranjbar, Tarek K Rajji, Maria Carmela Tartaglia, Aristotle N Voineskos, Benoit H Mulsant

Registry-linked trialOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Translational psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06591091 (Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06591091 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression

TypeinterventionalSponsorUniversity of Illinois at ChicagoRan2025 to 2026Enrolled80ConditionsDepressionArmsClemastine Fumarate, Placebo
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Plasma GFAP modifies the association of depressive symptoms with cognitive function: A population-based study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tulip MarawiInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Nicholas J AinsworthInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Peter ZhukovskyCampbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Neda Rashidi-RanjbarKeenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, Toronto, ON, Canada.
Tarek K RajjiInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-8324-2560
Maria Carmela TartagliaInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Aristotle N VoineskosInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-0156-0395
Benoit H MulsantInstitute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. benoit.mulsant@utoronto.ca.ORCID http://orcid.org/0000-0002-0303-6450
Centre for Addiction and Mental Health · CAUniversity of Toronto · CASt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost patients with late-life depression (LLD) have cognitive impairment, and at least one-third meet diagnostic criteria for mild cognitive impairment (MCI), a prodrome to Alzheimer's dementia (AD) and other neurodegenerative diseases. However, the mechanisms linking LLD and MCI, and brain alterations underlying impaired cognition in LLD and LLD + MCI remain poorly understood.

methodsTo address this knowledge gap, we conducted a systematic review of studies of brain-cognition relationships in LLD or LLD + MCI to identify circuits underlying impaired cognition in LLD or LLD + MCI. We searched MEDLINE, PsycINFO, EMBASE, and Web of Science databases from inception through February 13, 2023. We included studies that assessed cognition in patients with LLD or LLD + MCI and acquired: (1) T1-weighted imaging (T1) measuring gray matter volumes or thickness; or (2) diffusion-weighted imaging (DWI) assessing white matter integrity. Due to the heterogeneity in studies, we only conducted a descriptive synthesis.

resultsOur search identified 51 articles, resulting in 33 T1 studies, 17 DWI studies, and 1 study analyzing both T1 and DWI. Despite limitations, reviewed studies suggest that lower thickness or volume in the frontal and temporal regions and widespread lower white matter integrity are associated with impaired cognition in LLD. Lower white matter integrity in the posterior cingulate region (precuneus and corpus callosum sub-regions) was more associated with impairment executive function and processing speed than with memory.

conclusionFuture studies should analyze larger samples of participants with various degrees of cognitive impairment and go beyond univariate statistical models to assess reliable brain-cognition relationships in LLD.

Indexed as

Cognitive DysfunctionDepressionBrainCognitionHumansMagnetic Resonance Imaging

Identifiers

PMID37598228
PMCPMC10439902
OpenAlexW4386000033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.